Overview
Abdul Naqash is a Hematologist practicing medicine in Oklahoma City, Oklahoma.
Dr. Naqash is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Melanoma, Non-Small Cell Lung Cancer (NSCLC), Adult Soft Tissue Sarcoma, and Lung Cancer.
He is actively involved in clinical research, co-authoring 121 peer reviewed articles.
Specialties
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
800 NE 10th St # 4500, Oklahoma City, OK 73104
Additional Areas of Focus
Dr. Naqash has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ou Health Stephenson Cancer Center-Thoracic Cancer Clinic
Raid Aljumaily is a Hematologist practicing medicine in Oklahoma City, Oklahoma. Dr. Aljumaily is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma.
Ou Health Stephenson Cancer Center-Transplant & Cellular Therapy Clinic
Sami Ibrahimi is a Hematologist practicing medicine in Oklahoma City, Oklahoma. Dr. Ibrahimi is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Ou Health Stephenson Cancer Center-Gastrointestinal Cancer Clinic
Hassan Hatoum is a Hematologist practicing medicine in Oklahoma City, Oklahoma. Dr. Hatoum is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Familial Pancreatic Cancer.
Frequently Asked Questions about Dr. Abdul Naqash
How do I make an appointment with Dr. Abdul Naqash?
You can book an appointment with Dr. Abdul Naqash by calling their office at 405-271-1632. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Abdul Naqash a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Abdul Naqash is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Abdul Naqash specialize in?
While Dr. Abdul Naqash is a Hematology, they have specific expertise in Melanoma, Non-Small Cell Lung Cancer (NSCLC), and Adult Soft Tissue Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Abdul Naqash participate in research or clinical trials?
Yes. Dr. Abdul Naqash has published 121 articles and abstracts on conditions like Melanoma. You can view a list of Dr. Abdul Naqash's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Abdul Naqash accept my insurance?
Dr. Abdul Naqash accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 405-271-1632 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Naqash isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Lung CancerDr. Naqash isDistinguished. Learn about Lung Cancer.
- MelanomaDr. Naqash isDistinguished. Learn about Melanoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Naqash isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Alveolar Soft Part SarcomaDr. Naqash isAdvanced. Learn about Alveolar Soft Part Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Naqash isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Liver CancerDr. Naqash isAdvanced. Learn about Liver Cancer.
- Renal Cell Carcinoma (RCC)Dr. Naqash isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Small Cell Lung Cancer (SCLC)Dr. Naqash isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- WT1-Related Wilms Tumor SyndromesDr. Naqash isAdvanced. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- Adrenal CancerDr. Naqash isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Naqash isExperienced. Learn about Adrenocortical Carcinoma.
- AgranulocytosisDr. Naqash isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Naqash isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Breast CancerDr. Naqash isExperienced. Learn about Breast Cancer.
- Classical Hodgkin LymphomaDr. Naqash isExperienced. Learn about Classical Hodgkin Lymphoma.